Vaccine and Infectious Disease Division

Scientist with petri dish

Featured News from VIDD

Truvada

Truvada, already used to treat HIV+ persons, also helps prevent the virus from infecting healthy people.

Photo by Jeff Chiu / AP file


CDC recommends daily pill for those at high risk for HIV

The CDC recently recommended that Americans at high risk for HIV acquisition take a daily pill that’s been shown to prevent infection. This report recognizes the tremendous contribution VIDD faculty and staff have made to the field of HIV prevention research.

More Featured News from VIDD »

 

Upcoming VIDD Events

 

Seminar
VIDD Faculty Candidate Seminar
Tuesday, July 22
Note special time

Seminar
Steven Self, PhD
Tuesday, July 29
Pelton Auditorium

VIDD Faculty Stories

 

The hunt for HIV correlates of protection with Nicole Frahm
The importance of developing an effective HIV vaccine cannot be overstated. The statistics are sobering: over 35 million are infected worldwide; approximately 2 million people are infected each year; the estimated death toll from the virus thus far is 36 million; around 1.5 million died from HIV/AIDS in 2012; over 700 children become HIV infected each day.

More VIDD Faculty Stories »

VIDD Publication Spotlight

 

PrEPare yourself from HIV infection
Many types of pre-exposure prophylaxis (PrEP) have shown great promise for preventing HIV infection.

More VIDD News »

Find VIDD Faculty

 

International Spotlight

 

Uganda
Uganda offers a unique setting to study the impact of infections on the development and clinical course of several cancers.

More International Programs »

VIDD Announcements

 

VIDD announcements for faculty and staff promotions, new hires, awards, job openings and more.


Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect and treat cancer and other life-threatening diseases.